SCUBE Proteins in Polycystic Ovary Syndrome (IPSOS)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-35
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
About this trial
This study investigates circulating levels of SCUBE-1 and SCUBE-3 proteins in women with polycystic ovary syndrome (PCOS) compared with healthy controls. Differences between normoinsulinemic and hyperinsulinemic PCOS subgroups will be evaluated, as well as correlations with clinical and metabolic parameters related to inflammation and cardiovascular risk.
Eligibility criteria
Qualifiers
Female subjects aged 18-35 years
Diagnosis of polycystic ovary syndrome (normoinsulinemic or hyperinsulinemic)
Availability of basal hormonal evaluation and oral glucose tolerance test
Healthy women for control group
Disqualifiers
Pregnancy
History of cardiovascular disease
Diabetes mellitus or impaired glucose tolerance
Hypertension
Trial design
Treatments tested in this trial
- Blood Sample Collection for SCUBE-1 and SCUBE-3 Measurement
Treatment groups
56 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov